HALO
Halozyme Therapeutics Inc
109.90$
+2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.61 | 1.07 | 1.15 | 2.28 | 1.06 | 1.36 | 1.89 | 3.02 | 4.69 | 6.18 | 7.84 | 11.27 | |
| 0.19 | 0.23 | 0.26 | 0.22 | 0.07 | 0.32 | 0.31 | 0.55 | 0.99 | 1.43 | 1.23 | 2.47 | |
| 0.43 | 0.84 | 0.89 | 2.05 | 0.99 | 1.04 | 1.59 | 2.47 | 3.70 | 4.75 | 6.61 | 8.81 | |
| 0.65 | 0.74 | 1.18 | 1.08 | 1.05 | 0.98 | 0.24 | 0.24 | 0.47 | 0.57 | 0.61 | 0.66 | |
| 0.29 | 0.32 | 0.36 | 0.39 | 0.42 | 0.54 | 0.32 | 0.34 | 1.02 | 1.11 | 1.19 | 1.67 | |
| 0.94 | 1.05 | 1.54 | 1.47 | 1.47 | 1.51 | 0.57 | 0.59 | 1.80 | 2.23 | 2.35 | 2.22 | |
| -0.51 | -0.22 | -0.65 | 0.58 | -0.48 | -0.47 | 1.02 | 1.88 | 1.90 | 2.52 | 4.26 | 6.59 | |
| 0.05 | 0.04 | 0.16 | 0.16 | 0.13 | 0.08 | 0.14 | 0.05 | 0.12 | 0.14 | 0.14 | 0.15 | |
| -0.56 | -0.25 | -0.80 | 0.44 | -0.56 | -0.50 | 0.91 | 1.69 | 1.77 | 2.60 | 4.30 | 3.77 | |
| 0.03 | 0.03 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -1.05 | 0.33 | 0.50 | 0.87 | 1.21 | |
| -0.56 | -0.25 | -0.81 | 0.45 | -0.56 | -0.50 | 0.91 | 2.74 | 1.44 | 2.10 | 3.43 | 2.56 | |
| -0.50 | -0.20 | -0.63 | 0.60 | -0.47 | -0.44 | 1.04 | 1.90 | 2.24 | 3.37 | 5.07 | 4.62 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.